Compugen Quick Ratio 2006-2020 | CGEN

Historical quick ratio values for Compugen (CGEN) over the last 10 years.
Compugen Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-09-30 $0.00B $0.01B 0.00
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.01B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.01B 0.00
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.01B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.01B 0.00
2017-06-30 $0.00B $0.01B 0.00
2017-03-31 $0.00B $0.01B 0.00
2016-12-31 $0.00B $0.01B 0.00
2016-09-30 $0.00B $0.01B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.01B 0.00
2015-09-30 $0.00B $0.01B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.01B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.01B 0.00
2014-03-31 $0.00B $0.01B 0.00
2013-12-31 $0.00B $0.01B 0.00
2013-09-30 $0.00B $0.01B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B $0.00B 0.00
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $0.00B $0.00B 0.00
2008-03-31 $0.00B $0.00B 0.00
2007-12-31 $0.00B $0.00B 0.00
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $0.00B $0.00B 0.00
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
2006-03-31 $0.00B $0.00B 0.00
2005-12-31 $0.00B $0.00B 0.00
2005-09-30 $0.00B $0.00B 0.00
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.881B $0.018B
Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.214B 10.07
Amgen (AMGN) United States $131.035B 13.70
CSL (CSLLY) Australia $101.458B 0.00
Gilead Sciences (GILD) United States $76.616B 10.19
Vertex Pharmaceuticals (VRTX) United States $59.887B 27.85
Moderna (MRNA) United States $55.799B 0.00
Regeneron Pharmaceuticals (REGN) United States $54.854B 19.46
Illumina (ILMN) United States $48.814B 67.14
Biogen (BIIB) United States $37.418B 6.65
Seagen (SGEN) United States $31.988B 84.48
Alexion Pharmaceuticals (ALXN) United States $26.732B 10.65
BioNTech SE (BNTX) Germany $25.796B 0.00
Genmab (GMAB) Denmark $25.065B 29.64
Genmab (GNMSF) Denmark $23.371B 5.38
BeiGene (BGNE) Cayman Islands $22.381B 0.00
Incyte (INCY) United States $18.707B 0.00
Exact Sciences (EXAS) United States $18.537B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.013B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.596B 62.94
Alnylam Pharmaceuticals (ALNY) United States $15.367B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.123B 21.61
BioMarin Pharmaceutical (BMRN) United States $14.432B 95.78
ARGENX SE-ADR (ARGX) Netherlands $13.603B 0.00
Guardant Health (GH) United States $12.120B 0.00
Mirati Therapeutics (MRTX) United States $11.784B 0.00
Bio-Techne Corp (TECH) United States $11.774B 75.29
Sarepta Therapeutics (SRPT) United States $11.517B 0.00
QIAGEN (QGEN) Netherlands $11.037B 24.85
Repligen (RGEN) United States $10.201B 144.67
CRISPR Therapeutics AG (CRSP) Switzerland $9.155B 0.00
ACADIA Pharmaceuticals (ACAD) United States $9.028B 0.00
Ascendis Pharma (ASND) Denmark $9.007B 0.00
Galapagos (GLPG) Belgium $8.311B 0.00
Novavax (NVAX) United States $7.860B 0.00
Denali Therapeutics (DNLI) United States $7.500B 0.00
Acceleron Pharma (XLRN) United States $7.231B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.165B 0.00
Adaptive Biotechnologies (ADPT) United States $6.687B 0.00
Exelixis (EXEL) United States $5.944B 39.92
Amicus Therapeutics (FOLD) United States $5.897B 0.00
Blueprint Medicines (BPMC) United States $5.888B 19.49
SWEDISH ORP BIO (BIOVF) Sweden $5.776B 15.78
Halozyme Therapeutics (HALO) United States $5.490B 253.81
Twist Bioscience (TWST) United States $5.333B 0.00
Fate Therapeutics (FATE) United States $5.254B 0.00
NeoGenomics (NEO) United States $5.228B 1569.67
Reata Pharmaceuticals (RETA) United States $5.145B 0.00
China Biologic Products (CBPO) China $4.669B 30.26
Emergent Biosolutions (EBS) United States $4.368B 14.33
Insmed (INSM) United States $3.987B 0.00
Vir Biotechnology (VIR) United States $3.978B 0.00
Legend Biotech (LEGN) United States $3.882B 0.00
Arena Pharmaceuticals (ARNA) United States $3.845B 0.00
MorphoSys AG (MOR) Germany $3.714B 134.43
Eidos Therapeutics (EIDX) United States $3.601B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.418B 0.00
Beam Therapeutics (BEAM) United States $3.180B 0.00
Bluebird Bio (BLUE) United States $3.045B 0.00
Global Blood Therapeutics (GBT) United States $2.977B 0.00
Alkermes (ALKS) Ireland $2.938B 28.84
Zymeworks (ZYME) Canada $2.505B 0.00
Seres Therapeutics (MCRB) United States $2.404B 0.00
Intellia Therapeutics (NTLA) United States $2.251B 0.00
UniQure (QURE) Netherlands $2.213B 0.00
Viela Bio (VIE) United States $2.178B 0.00
PHARMA MAR SA (PHMMF) Spain $2.148B 0.00
I-Mab (IMAB) China $2.118B 0.00
Inovio Pharmaceuticals (INO) United States $2.104B 0.00
Sorrento Therapeutics (SRNE) United States $2.101B 0.00
Alcobra (ARCT) United States $1.995B 0.00
Editas Medicine (EDIT) United States $1.988B 0.00
Amarin (AMRN) Ireland $1.920B 0.00
Intra-Cellular Therapies (ITCI) United States $1.916B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.858B 0.00
Mersana Therapeutics (MRSN) United States $1.774B 0.00
Mesoblast (MESO) Australia $1.774B 0.00
Arcus Biosciences (RCUS) United States $1.752B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.694B 0.00
Scholar Rock Holding (SRRK) United States $1.637B 0.00
NGM Biopharmaceuticals (NGM) United States $1.614B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.599B 0.00
Precigen (PGEN) United States $1.528B 0.00
Zealand Pharma (ZEAL) Denmark $1.485B 0.00
Sangamo Therapeutics (SGMO) United States $1.427B 0.00
Myriad Genetics (MYGN) United States $1.403B 0.00
REGENXBIO (RGNX) United States $1.364B 0.00
Epizyme (EPZM) United States $1.352B 0.00
Ligand Pharmaceuticals (LGND) United States $1.349B 34.95
Coherus BioSciences (CHRS) United States $1.346B 8.90
Adverum Biotechnologies (ADVM) United States $1.334B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Cytokineticsorporated (CYTK) United States $1.241B 0.00
Athenex (ATNX) United States $1.241B 0.00
Genetron Holdings (GTH) China $1.232B 0.00
Travere Therapeutics (TVTX) United States $1.184B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.178B 0.00
Vericel (VCEL) United States $1.173B 0.00
Heska (HSKA) United States $1.172B 0.00
Northwest Biotherapeutics (NWBO) United States $1.145B 0.00
Cellectis S.A (CLLS) France $1.140B 0.00
Codexis (CDXS) United States $1.129B 0.00
Alector (ALEC) United States $1.075B 0.00
Pliant Therapeutics (PLRX) United States $1.064B 0.00
NantKwest (NK) United States $1.053B 0.00
Arvinas (ARVN) United States $1.000B 0.00
Castle Biosciences (CSTL) United States $0.992B 0.00
Morphic Holding (MORF) United States $0.965B 0.00
Frequency Therapeutics (FREQ) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.930B 0.00
Protagonist Therapeutics (PTGX) United States $0.886B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.884B 0.00
Pharming Group (PHGUF) Netherlands $0.882B 20.14
Celldex Therapeutics (CLDX) United States $0.861B 0.00
Cardiff Oncology (CRDF) United States $0.818B 0.00
VBI Vaccines (VBIV) United States $0.767B 0.00
MiMedx (MDXG) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.732B 0.00
Agenus (AGEN) United States $0.723B 0.00
Albireo Pharma (ALBO) United States $0.720B 0.00
Kadmon Holdings (KDMN) United States $0.712B 0.00
MannKind (MNKD) United States $0.695B 0.00
AnaptysBio (ANAB) United States $0.676B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.675B 34.28
Five Prime Therapeutics (FPRX) United States $0.668B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.663B 0.00
Sutro Biopharma (STRO) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.637B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.618B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.611B 0.00
Precision BioSciences (DTIL) United States $0.603B 0.00
IVERIC Bio (ISEE) United States $0.590B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
Geron (GERN) United States $0.571B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.536B 0.00
Anika Therapeutics (ANIK) United States $0.532B 71.96
MeiraGTx Holdings (MGTX) United States $0.526B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.520B 0.00
Avid Bioservices (CDMO) United States $0.497B 0.00
Merus (MRUS) Netherlands $0.496B 0.00
Puma Biotechnology (PBYI) United States $0.476B 0.00
Cel-Sci (CVM) United States $0.474B 0.00
Forte Biosciences (FBRX) United States $0.473B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.472B 0.00
Spero Therapeutics (SPRO) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.439B 0.00
WAVE Life Sciences (WVE) Singapore $0.437B 0.00
Innate Pharma S.A (IPHA) France $0.434B 0.00
Clovis Oncology (CLVS) United States $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
UROGEN PHARMA (URGN) United States $0.421B 0.00
Kala Pharmaceuticals (KALA) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.410B 0.00
Affimed (AFMD) Germany $0.404B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.402B 0.00
Starpharma Holdings (SPHRY) Australia $0.396B 0.00
AC Immune SA (ACIU) Switzerland $0.394B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 18.09
Trevena (TRVN) United States $0.372B 0.00
Selecta Biosciences (SELB) United States $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.366B 0.00
XOMA (XOMA) United States $0.361B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.360B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Verastem (VSTM) United States $0.355B 0.00
Athersys (ATHX) United States $0.354B 0.00
ANI Pharmaceuticals (ANIP) United States $0.349B 8.87
CytomX Therapeutics (CTMX) United States $0.348B 0.00
Arbutus Biopharma (ABUS) United States $0.339B 0.00
ChromaDex (CDXC) United States $0.310B 0.00
Kamada (KMDA) Israel $0.300B 14.04
NextCure (NXTC) United States $0.296B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.295B 0.00
PDL BioPharma (PDLI) United States $0.291B 0.00
CorMedix Inc (CRMD) United States $0.278B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
IBio (IBIO) United States $0.264B 0.00
AquaBounty Technologies (AQB) United States $0.259B 0.00
Pluristem Therapeutics (PSTI) Israel $0.256B 0.00
Fortress Biotech (FBIO) United States $0.255B 0.00
HOOKIPA Pharma (HOOK) United States $0.251B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Aptinyx (APTX) United States $0.224B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.216B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
Nicox SA (NICXF) France $0.207B 0.00
Cerecor (CERC) United States $0.193B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
Eton Pharmaceuticals (ETON) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Bellus Health (BLU) Canada $0.184B 0.00
Aptevo Therapeutics (APVO) United States $0.183B 0.00
Strongbridge Biopharma (SBBP) United States $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.174B 0.00
Theratechnologies (THTX) Canada $0.174B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.172B 0.00
Dyadic (DYAI) United States $0.170B 0.00
SESEN BIO, INC (SESN) United States $0.167B 0.00
VolitionRX (VNRX) United States $0.159B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Idera Pharmaceuticals (IDRA) United States $0.154B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Kindred Biosciences (KIN) United States $0.152B 0.00
Abeona Therapeutics (ABEO) United States $0.150B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Oncobiologics (OTLK) United States $0.146B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.142B 0.00
Celyad SA (CYAD) Belgium $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.132B 0.00
Exicure (XCUR) United States $0.129B 0.00
Lumos Pharma (LUMO) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.125B 0.00
TRACON Pharmaceuticals (TCON) United States $0.124B 0.00
Cogent Biosciences (COGT) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Gritstone Oncology (GRTS) United States $0.113B 0.00
Cocrystal Pharma (COCP) United States $0.113B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.112B 0.00
Orgenesis (ORGS) United States $0.112B 231.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Aytu Bioscience (AYTU) United States $0.111B 0.00
Palatin Technologies (PTN) United States $0.106B 0.00
Windtree Therapeutics (WINT) United States $0.106B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.101B 0.00
DiaMedica Therapeutics (DMAC) United States $0.097B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Novogen (KZIA) Australia $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Prometic Life Sciences (LMNL) Canada $0.093B 0.00
Clearside Biomedical (CLSD) United States $0.092B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Curis (CRIS) United States $0.090B 0.00
Evogene (EVGN) Israel $0.090B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Prima BioMed (IMMP) Australia $0.077B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 33.25
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Soligenix (SNGX) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
MiRagen Therapeutics (MGEN) United States $0.066B 0.00
Armata Pharmaceuticals (ARMP) United States $0.060B 0.00
Appili Therapeutics (APLIF) Canada $0.060B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Vascular Biogenics (VBLT) Israel $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Seelos Therapeutics (SEEL) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.046B 0.00
Pulmatrix (PULM) United States $0.046B 0.00
Genetic Technologies (GENE) Australia $0.045B 0.00
ATyr Pharma (LIFE) United States $0.043B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.031B 0.00
BioCardia (BCDA) United States $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Celsion (CLSN) United States $0.023B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
Spherix (AIKI) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00